Preoperative diagnosis and management of inherited bleeding disorders in female adolescents and adults

Although inherited bleeding disorders (IBDs) affect both females and males, this review of the preoperative diagnosis and management of IBDs focuses on genetic and gynecologic screening, diagnosis and management of affected and carrier females. A PubMed literature search was conducted, and the peer-reviewed literature on IBDs was evaluated and summarized. Best-practice considerations for screening, diagnosis and management of IBDs in female adolescents and adults, with GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) evidence level and ranking of recommendation strength, are presented. Health care providers need to increase their recognition of and support for female adolescents and adults with IBDs. Improved access to counselling, screening, testing and hemostatic management is also required. Patients should be educated and encouraged to report abnormal bleeding symptoms to their health care provider when they have a concern. It is hoped that this review of preoperative IBD diagnosis and management will enhance access to women-centred care to increase patients’ understanding of IBDs and decrease their risk of IBD-related morbidity and mortality.

[1]  J. Douketis,et al.  Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis , 2022, Mayo Clinic proceedings. Innovations, quality & outcomes.

[2]  Y. Vinogradova,et al.  Medical treatment for heavy menstrual bleeding in primary care: 10-year data from the ECLIPSE trial , 2022, The British journal of general practice : the journal of the Royal College of General Practitioners.

[3]  W. Miesbach,et al.  Von Willebrand Disease-Specific Aspects in Women. , 2022, Hamostaseologie.

[4]  W. Cantor,et al.  A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes , 2022, Canadian Medical Association Journal.

[5]  M. Paulis,et al.  Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders , 2022, Cells.

[6]  T. Renné,et al.  An Update on Safe Anticoagulation. , 2022, Hamostaseologie.

[7]  Hester F. Lingsma,et al.  Patient‐reported outcomes in autosomal inherited bleeding disorders: A systematic literature review , 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  Á. Taype-Rondan,et al.  Effects of replacement therapies with clotting factors in patients with hemophilia: A systematic review and meta-analysis , 2022, PloS one.

[9]  F. Peyvandi,et al.  Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy , 2022, Pain and Therapy.

[10]  J. Astermark,et al.  International consensus recommendations on the management of people with haemophilia B , 2022, Therapeutic advances in hematology.

[11]  M. Holland,et al.  The lived experience of women with a bleeding disorder: A systematic review , 2022, Research and practice in thrombosis and haemostasis.

[12]  Maximo J Marin,et al.  Von Willebrand factor and disease: a review for laboratory professionals , 2021, Critical reviews in clinical laboratory sciences.

[13]  J. Oldenburg,et al.  Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study , 2021, Journal of clinical medicine.

[14]  A. Ma,et al.  Factor-mimetic and rebalancing therapies in hemophilia A and B: the end of factor concentrates? , 2021, Hematology. American Society of Hematology. Education Program.

[15]  L. George,et al.  Hemophilia gene therapy: ushering in a new treatment paradigm? , 2021, Hematology. American Society of Hematology. Education Program.

[16]  R. Kadir,et al.  Pregnancy in special populations: challenges and solutions practical aspects of managing von Willebrand disease in pregnancy. , 2021, Hematology. American Society of Hematology. Education Program.

[17]  A. Taher,et al.  Clinical burden of hemophilia in older adults: Beyond bleeding risk. , 2021, Blood reviews.

[18]  Y. Dargaud,et al.  Clinical Utility of Subcutaneous Factor VIII Replacement Therapies in Hemophilia A: A Review of the Evidence , 2021, Journal of blood medicine.

[19]  B. Wiratama,et al.  Efficacy, safety, and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trials. , 2021, F1000Research.

[20]  C. Miller The Clinical Genetics of Hemophilia B (Factor IX Deficiency) , 2021, The application of clinical genetics.

[21]  Baoyu Lei,et al.  Congenital hemophilia A with low activity of factor XII: a case report and literature review , 2021, Italian Journal of Pediatrics.

[22]  R. Sidonio,et al.  Hemophilia B (Factor IX Deficiency). , 2021, Hematology/oncology clinics of North America.

[23]  C. Königs,et al.  Hemophilia treatment in 2021: Choosing the"optimal" treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. , 2021, Blood reviews.

[24]  J. Astermark,et al.  Identification of F8 rearrangements in carrier and non‐carrier mothers of haemophilia A patients , 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

[25]  M. Ragni,et al.  Hemophilia A (Factor VIII Deficiency). , 2021, Hematology/oncology clinics of North America.

[26]  P. Kouides,et al.  Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II). , 2021, Hematology/oncology clinics of North America.

[27]  O. Barel,et al.  Molecular Mechanisms of Skewed X-Chromosome Inactivation in Female Hemophilia Patients—Lessons from Wide Genome Analyses , 2021, International journal of molecular sciences.

[28]  E. Favaloro,et al.  Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations , 2021, Journal of blood medicine.

[29]  L. Patton,et al.  World Workshop on Oral Medicine VII: Bleeding control interventions for invasive dental procedures in patients with inherited functional platelet disorders: A systematic review. , 2021, Oral surgery, oral medicine, oral pathology and oral radiology.

[30]  M. Othman,et al.  A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH , 2021, Journal of thrombosis and haemostasis : JTH.

[31]  C. McGuinn,et al.  Haemophilia: factoring in new therapies , 2021, British journal of haematology.

[32]  P. Kouides,et al.  Regulation and importance of factor VIII levels in hemophilia A carriers , 2021, Current opinion in hematology.

[33]  S. Mangles,et al.  Haemophilia Carriers Experience Study (CARES): A mixed method exploration into the experience of women who are carriers of Haemophilia , 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

[34]  A. Jerath,et al.  Tranexamic acid: current use in obstetrics, major orthopedic, and trauma surgery , 2021, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[35]  J. González-Porras,et al.  Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia , 2021, International journal of molecular sciences.

[36]  G. Castaman,et al.  Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives , 2021, Journal of blood medicine.

[37]  J. Middeldorp,et al.  Maternal and neonatal bleeding complications in relation to peripartum management in hemophilia carriers: A systematic review. , 2021, Blood reviews.

[38]  P. Bignell,et al.  Factor VIII levels and bleeding according to factor 8 (F8) mutation in pregnant carriers of haemophilia A: a multicentre retrospective cohort study , 2021, British journal of haematology.

[39]  J. Kujovich,et al.  Delivery and neuraxial technique outcomes in patients with hemophilia and in hemophilia carriers: a systematic review , 2021, Journal of Anesthesia.

[40]  V. Arruda,et al.  Gene Therapy for Inherited Bleeding Disorders , 2021, Seminars in Thrombosis and Hemostasis.

[41]  R. Mustafa,et al.  ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. , 2021, Blood advances.

[42]  M. Franchini,et al.  Prophylactic management of patients with von Willebrand disease , 2021, Therapeutic advances in hematology.

[43]  R. Sidonio,et al.  Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[44]  C. Miller,et al.  Genetic causes of haemophilia in women and girls , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[45]  L. Pérez Hemophilia carriers and women with coagulopathies: challenges in the occupational arena. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[46]  M. E. Mingot Castellano General concepts on hemophilia A and on women carrying the disease. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[47]  F. Vidal State of the art of genetic studies in hemophilia carriers. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[48]  A. Torres-Ortuño Hemophilia carriers: quality of life and management at different life stages. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[49]  María Caridad Falcón Rodríguez Carriers of haemophilia: pregnancy, childbirth and postpartum. , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[50]  J. C. García-Lozano,et al.  Prenatal diagnostic techniques and IVF in patients with coagulopathies , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[51]  E. Santagostino,et al.  X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers , 2020, European Journal of Human Genetics.

[52]  S. Pasca,et al.  Haemophilia A/B carriers: haemorrhagic burden of disease and open issues. , 2020, Blood transfusion = Trasfusione del sangue.

[53]  P. Batty,et al.  Postpartum bleeding in women with inherited bleeding disorders: a matched cohort study , 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[54]  F. Leebeek,et al.  How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease. , 2020, Blood.

[55]  E. Quint,et al.  Outpatient Management of Heavy Menstrual Bleeding in Adolescent and Young Women with Inherited Platelet Function Disorders. , 2020, Journal of Pediatric and Adolescent Gynecology.

[56]  J. Johnsen,et al.  von Willebrand disease: Diagnosis and treatment, treatment of women, and genomic approach to diagnosis , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[57]  W. Miesbach Perioperative management for patients with von Willebrand disease: Defining the optimal approach , 2020, European journal of haematology.

[58]  K. Fischer,et al.  The experiences and attitudes of hemophilia carriers around pregnancy: A qualitative systematic review , 2020, Journal of thrombosis and haemostasis : JTH.

[59]  C. Djambas Khayat,et al.  Heavy menstrual bleeding in women with inherited bleeding disorders , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[60]  D. Page Setting the scene: Historical overview of challenges and what led to advances in comprehensive care in developed countries, the Canadian experience , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[61]  G. Castaman,et al.  Hemophilia management: Huge impact of a tiny difference , 2020, Research and practice in thrombosis and haemostasis.

[62]  P. Mannucci Hemophilia therapy: the future has begun , 2020, Haematologica.

[63]  S. Evans Hematopoietic , 2020, Definitions.

[64]  K. V. van Galen,et al.  Menstrual and obstetrical bleeding in women with inherited platelet receptor defects—A systematic review , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[65]  A. Iorio,et al.  Clinical application of Web Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS‐Hemo): Patterns of blood sampling and patient characteristics among clinician users , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

[66]  P. Mannucci New therapies for von Willebrand disease. , 2019, Blood advances.

[67]  P. Mannucci,et al.  Factor VIII replacement is still the standard of care in haemophilia A. , 2019, Blood transfusion = Trasfusione del sangue.

[68]  P. Noris,et al.  Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report , 2019, HemaSphere.

[69]  K. Robinson,et al.  Women and inherited bleeding disorders - A review with a focus on key challenges for 2019. , 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[70]  S. Dunkley,et al.  Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy , 2019, The Medical journal of Australia.

[71]  S. Dunn,et al.  No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women. , 2018, Journal of Obstetrics and Gynaecology Canada.

[72]  P. James,et al.  Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception? , 2018, Contraception.

[73]  J. Staber,et al.  The spectrum of bleeding in women and girls with haemophilia B , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[74]  Nicoleta P. Berbec,et al.  Von Willebrand Disease type 2 in pregnancy - A critical clinical association. , 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[75]  A. Harris,et al.  Treatment of hemophilia: A qualitative study of mothers’ perspectives , 2017, Pediatric blood & cancer.

[76]  B. Moiz,et al.  Use of ISTH bleeding assessment tool to predict inherited platelet dysfunction in resource constrained settings , 2016, Scandinavian journal of clinical and laboratory investigation.

[77]  M. Grootenhuis,et al.  Psychosocial functioning of mothers of boys with haemophilia , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[78]  P. James,et al.  Using genetic diagnostics in hemophilia and von Willebrand disease. , 2015, Hematology. American Society of Hematology. Education Program.

[79]  R. Ljung,et al.  Prenatal diagnosis of haemophilia in Sweden now more commonly used for psychological preparation than termination of pregnancy , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[80]  Shamim A. Mollah,et al.  Normal range of bleeding scores for the ISTH‐BAT: adult and pediatric data from the merging project , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[81]  R. Ljung,et al.  Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B , 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[82]  R. Ljung,et al.  Increased burden on caregivers of having a child with haemophilia complicated by inhibitors , 2014, Pediatric blood & cancer.

[83]  Melissa K Cousino,et al.  Parenting stress among caregivers of children with chronic illness: a systematic review. , 2013, Journal of pediatric psychology.

[84]  P. James,et al.  von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies , 2012, American journal of hematology.

[85]  J. Platt Women and girls , 2012 .

[86]  A. James Diagnosis and management of women with bleeding disorders – international guidelines and consensus from an international expert panel , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[87]  A. Tosetto,et al.  How I treat von Willebrand disease. , 2009, Blood.

[88]  B. Siegmund,et al.  Quality of life, psychosocial strains and coping in parents of children with haemophilia , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[89]  R. Miller,et al.  Carrier testing in haemophilia A and B: adult carriers’ and their partners’ experiences and their views on the testing of young females , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[90]  V. Byams,et al.  Women with bleeding disorders. , 2007, Journal of women's health.

[91]  L. Zimmerman Causes and Consequences of Critical Bleeding and Mechanisms of Blood Coagulation , 2007, Pharmacotherapy.

[92]  A. James,et al.  Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease , 2007, Journal of thrombosis and haemostasis : JTH.

[93]  N. Kanayama,et al.  Congenital Blood Coagulation Factor XIII Deficiency and Successful Deliveries: A Review of the Literature , 2007, Obstetrical & gynecological survey.

[94]  J. Higham,et al.  Assessment of menstrual blood loss using a pictorial chart , 1990, British journal of obstetrics and gynaecology.

[95]  C. Moutou,et al.  ESHRE PGD Consortium data collection XIV–XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013 , 2017, Human reproduction.

[96]  L. Bradley,et al.  The medical management of abnormal uterine bleeding in reproductive-aged women. , 2016, American journal of obstetrics and gynecology.

[97]  G. Lippi,et al.  Inherited platelet disorders. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[98]  H. Kawame [Carrier testing]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[99]  M. Kroll,et al.  Acquired disorders of platelet function. , 2005, Hematology. American Society of Hematology. Education Program.

[100]  D. Ginsburg,et al.  Von Willebrand disease. , 2008, Pediatric clinics of North America.